Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Evolent Health, Inc (EVH : NYSE)
 
 • Company Description   
Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia.

Number of Employees: 4,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $11.79 Daily Weekly Monthly
20 Day Moving Average: 3,010,720 shares
Shares Outstanding: 117.40 (millions)
Market Capitalization: $1,384.14 (millions)
Beta: 1.01
52 Week High: $33.63
52 Week Low: $7.06
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 41.54% 35.25%
12 Week 17.55% 0.40%
Year To Date 4.80% -1.84%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1812 N. MOORE STREET SUITE 1705
-
ARLINGTON,VA 22209
USA
ph: 571-389-6000
fax: 571-389-6001
sfrank@evolent.com http://www.evolent.com
 
 • General Corporate Information   
Officers
Seth Blackley - Chief Executive Officer and Director
John Johnson - Chief Financial Officer
Aammaad Shams - Chief Accounting Officer
Toyin Ajayi - Director
Craig Barbarosh - Director

Peer Information
Evolent Health, Inc (HLIS)
Evolent Health, Inc (AZTA)
Evolent Health, Inc (APYI)
Evolent Health, Inc (RNVA)
Evolent Health, Inc (HMSY)
Evolent Health, Inc (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 30050B101
SIC: 8741
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 117.40
Most Recent Split Date: (:1)
Beta: 1.01
Market Capitalization: $1,384.14 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.02 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 673.71
Trailing 12 Months: 117.90
PEG Ratio: -
Price Ratios
Price/Book: 1.48
Price/Cash Flow: 7.77
Price / Sales: 0.58
EPS Growth
vs. Year Ago Period: -125.00%
vs. Previous Quarter: -233.33%
Sales Growth
vs. Year Ago Period: -24.39%
vs. Previous Quarter: -25.19%
ROE
06/30/25 - -
03/31/25 - 3.64
12/31/24 - 5.79
ROA
06/30/25 - -
03/31/25 - 1.44
12/31/24 - 2.36
Current Ratio
06/30/25 - -
03/31/25 - 0.98
12/31/24 - 0.85
Quick Ratio
06/30/25 - -
03/31/25 - 0.98
12/31/24 - 0.85
Operating Margin
06/30/25 - -
03/31/25 - 1.53
12/31/24 - 2.35
Net Margin
06/30/25 - -
03/31/25 - -4.54
12/31/24 - -2.41
Pre-Tax Margin
06/30/25 - -
03/31/25 - -4.56
12/31/24 - -2.47
Book Value
06/30/25 - -
03/31/25 - 7.97
12/31/24 - 8.70
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.69
12/31/24 - 0.49
Debt-to-Capital
06/30/25 - -
03/31/25 - 36.45
12/31/24 - 29.16
 

Powered by Zacks Investment Research ©